Bearing Point Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bearing Point Capital's LLY Position: Q3 2026 in Review
Bearing Point Capital increased its Eli Lilly (LLY) stake by 1.6% in Q3 2026, buying an estimated $133K and bringing the position to 7,288 shares worth $8.43M. The position accounts for 1.09% of the portfolio, ranked #29.
Bearing Point Capital first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $8.61M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Bearing Point Capital held 7,288 shares of Eli Lilly worth $8.43M as of Q3 2026.
- Bearing Point Capital bought 113 Eli Lilly shares in Q3 2026, an estimated $133K.
- Eli Lilly made up 1.09% of Bearing Point Capital's portfolio in Q3 2026, its #29 holding.
- Bearing Point Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- Bearing Point Capital's Eli Lilly position peaked at $8.61M in Q2 2026.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Bearing Point Capital's 13F filing for Q3 2026, filed 13 Nov 2026.